“showed a trend”

In general, the WT strain showed a trend to higher GalN relative abundance compared to Gal, whereas in the M1 ( barA ), M3 ( thyA ) and M8 (E1N14_01730) mutants the Gal content was highest (Table 2 ).

An analysis of candidate genes associated with DDR and PI3K/AKT/mTOR signaling showed a trend towards greater copy number amplifications in the PR group.

S 7 H showed a trend for the subgroup TP53(−) & ALG3(Low) but it was not significant for outcome after RT in the other subgroups, which was consistent with that both TP53 mutation [ 85 ] and ALG3 overexpression would significantly influence the radiosensitivity of breast cancer.

The choice of anxiolytic medication showed a trend toward a more frequent use of benzodiazepines in patients with agitation compared to all other patients (6/6 vs. 4/12), while low-dose morphine was used less frequently (2/6 vs. 7/12). 28-day-, in hospital- and 6-month mortality rates were 44% (8/18), 50% (9/18) and 50%, respectively.

Regarding total SCFA, the SYN and CTR− groups showed a trend for a decreased concentration compared to the other groups (P treatment = 0.085) at day 4 PI but not at day 8 PI.

With the increase in TC levels, the effective rate of treatment showed a trend of initially increasing and then decreasing, with an overall inverted “U” shape ( Figure 4 ).

The CUSUM 0° line achieved good prior performance at case 45, CUSUM 90° and 120° showed a trend toward good prior performance, while CUSUM 45° reached poor prior performance at case 8.

In a parallel experiment, we tested the effect of this congenic locus on myopathy and observed a dosage effect, whereby Col4a1 +/Δex41 mice that were heterozygous at the MoGS1 locus ( MoGS1 C/B ) showed a trend toward reduced myopathy, while homozygous MoGS1 C/C incipient congenic mice had significantly milder myopathy compared to mice that were homozygous for the B6 allele ( MoGS1 B/B ).

Deceased patients exhibited a trend toward lower CR1/E levels, CR1/E was lower in older patients known to be at risk for more severe disease, the physiological index IGS2 at ICU admission was inversely related to CR1/E level, D-Dimer levels showed a trend in the same direction, and CR1/E was lower among patients with a refractory hypoxemia.

A comparative real-world analysis of 88 Taiwanese patients with brain metastases at baseline showed a trend towards a reduction in risk among patients treated with afatinib compared with gefitinib [ 31 ] (Table 2 ).

Patients with higher body weight showed a trend of higher cemiplimab exposure with 3 mg/kg Q2W; the trend was reversed for 350 mg Q3W.

Moreover, while IgG tended to stabilize in mild cases, severe cases showed a trend toward more sustained antibody response in time.

Indeed, as shown in Table 1 , while experts showed a trend toward higher bird sensitivity, this was also seen for human motion, for which experts and novices should have equal experience.

The second quantile group (Q2) and the third quantile group (Q3) showed no significant difference in the risk of disease compared with Q1 but showed a trend of decreasing risk as the quantile group increased (the trend P values were both <0.05).

Conclusion Dimethyl fumarate showed a trend towards reduction in T25FW but no evidence of clinically significant impact on EDSS.

No significant differences were observed between genotypes, although, in both treatments, TR1 and TR4 showed a trend to produce more biomass (from 10 to 14%) than the WT (Table 5 ).

4/8 categories (RTAs, falls < 2m, malignancy, miscellaneous) showed a trend towards return of pre-lockdown values during SP2.

This finding showed a trend of severe presentation in older age group.

gba2 KO medaka showed a trend towards an increase in sphingolipids in the brains, which is one of the possible causes of asyn accumulation.

For sub-freezing, the amino acid metabolism showed a trend of falling at the beginning and subsequent rising, but the carbohydrate metabolism was no regular change.

The delayed resuscitation group also showed a trend toward fewer complications and had a significant reduction in length of hospital stay.

ICU patients treated with triple therapy showed a trend towards more oliguric or anuric kidney injury.

Influence of Set-Flow on Actual-FiO 2 in a Single Device Actual-FiO 2 of AIRVO 2, TNI softFlow 50, and HUMID-BH showed a trend that, with the increase in set-FiO 2 and set-flow, the difference between the actual-FiO 2 and set-FiO 2 became greater (Figures 4(b) , 4(c) , and 4(e) ).

Patients in whom the treatment was assessed as effective [achieved complete response (CR)/partial response (PR) or showed a trend of hematological improvement] at Week 26 entered the extension phase to continue treatment until the product became commercially available.

Two weeks later, an NCS was repeated and showed a trend toward improvement (extended distal latency in the left median nerve 4.7 ms, reduced F wave in the left median nerve 69%).